Stanley DiDomenico

Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulation

Jun Chen, Shailen K. Joshi, Stanley DiDomenico et al. · Pain · 2011 · 271 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Novel Transient Receptor Potential Vanilloid 1 Receptor Antagonists for the Treatment of Pain:  Structure−Activity Relationships for Ureas with Quinoline, Isoquinoline, Quinazoline, Phthalazine, Quinoxaline, and Cinnoline Moieties

Arthur Gomtsyan, Erol K. Bayburt, Robert G. Schmidt et al. · Journal of Medicinal Chemistry · 2005 · 163 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Design of Adenosine Kinase Inhibitors from the NMR-Based Screening of Fragments

Philip J. Hajduk, Arthur Gomtsyan, Stanley DiDomenico et al. · Journal of Medicinal Chemistry · 2000 · 65 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease.

Kazumi Shiosaki, Peter Jenner, Karen E. Asin et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 63 citations

Medicine, Medicinal Chemistry, Pharmacology +17

(5aR,11bS)-4,5,5a,6,7,11b-Hexahydro-2-propyl-3-thia-5-azacyclopent-1-ena[c]phenanthrene-9,10-diol (A-86929): a potent and selective dopamine D1 agonist that maintain behavioral efficacy following repeated administration and characterization of its diacetyl prodrug (ABT-431)

Michael R. Michaelides, Yufeng Hong, Stanley DiDomenico et al. · Journal of Medicinal Chemistry · 1995 · 63 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12